News
A well-connected drug company and Laura Loomer wanted Kennedy ally Vinay Prasad gone. Trump Chief of Staff Susie Wiles got ...
14hOpinion
Drug Approvals Hit an FDA Wall
Therapies for rare and deadly disease are dying in Marty Makary’s shop.
Prasad Returns, Delany Departs, Lilly’s Weight Loss Pill Disappoints and Sarepta’s Fallout Continues
CBER Chief Vinay Prasad reclaimed his job less than two weeks after his mysterious exit; MAHA implementor Gray Delany is out ...
The FDA’s top vaccine regulator is returning to his post less than 2 weeks after the White House had him ousted.
In our Venable FDA Pulse series, we report on critical developments within the Food and Drug Administration (FDA or the Agency) that may affect ...
Pharmaceutical Technology on MSN1d
Prasad’s shock FDA return reignites regulatory uncertainty
Vinay Prasad resumes leadership at the FDA’s CBER two weeks after he resigned amid cell and gene therapy controversy.
This episode of Pharma Pulse covers Vinay Prasad’s return to lead the FDA’s biologics center after a brief resignation, new ...
Health and Me on MSN2d
FDA Vaccination Chief Vinay Prasad Returns To Job Within Days After Quitting Under Pressure, Who Is He?
Dr. Vinay Prasad, ousted as FDA’s top vaccine and gene therapy regulator amid political backlash, has been reinstated. Known ...
Dr. Vinay Prasad is resuming leadership of the FDA center that regulates vaccines and biotech therapies, a spokesperson for ...
Dr Vinay Prasad has resigned from the FDA after less than three months amid controversy over Sarepta Therapeutics' gene therapy and pressure from the White House. He plans to return to California ...
Dr. Vinay Prasad is stepping down as the Food and Drug Administration’s top vaccine regulator after a brief tenure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback